2011 release index
The ICMS is always making news.
From new clinics entering the accreditation program to major statements on topics that are critical to the advancement of adult stem cell medicine, the ICMS is the voice of the physician and patient.
December 14, 2011 - The International Cellular Medicine Society (ICMS), a professional medical association dedicated to the advancement of cell-based therapies through standards, peer oversight and physician education, announced an agreement with Medical Protective (Med Pro) to provide a line of professional liability coverage for ICMS members providing cell-based therapies. More.
November 21, 2011- The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS)jointly announced todaythe ICMS Institutional Review Board’s (IRB) approval of the first study to use autologous brain-like or neural stem cells for multiple sclerosis. More.
November 14, 2011 - The ICMS announced its findings from an investigation into the death of a patient who had received an autologous treatment of adipose derived stem cells at the Institute for Regenerative Medicine (RMI) in Tijuana, Mexico. More.
November 8, 2011 - The ICMS announces the preliminary agenda for its 4th Annual International Congress on Regenerative and Cell-Based Medicine to be held in Hollywood, Florida in May 2012. More.
October 31, 2001 - The ICMS announced it has initiated an investigation in the death of patient who had undergone an autologous, adipose derived stem cell treatment in Tijuana, Mexico. More.
October 23, 2011 - The AABB announced an alliance with the ICMS to explore a new program to evaluate the practices, facilities and protocols for clinics providing cell-based therapies. This first-of-its-kind relationship will align the global leaders in standards, accreditation and educational programs to focus on patient care and safety. More.
September 14, 2011 – The International Cellular Medicine Society (“ICMS”), a professional medical association dedicated to the advancement of adult stem cell therapies, issued a letter to the clinics seeking accreditation warning them of issues with potentially misleading claims about their accreditation status. More
September 13, 2011 – The International Cellular Medicine Society (“ICMS”), a professional medical association dedicated to the advancement of adult stem cell therapies, announced the publication of new draft guidelines for the practice of cell based medicine. The new draft guidelines, developed in consultation with physicians and researchers from around the world, are intended to provide a broader and more comprehensive element to the existing standards for the collection, processing and implantation of autologous, adult stem cells. More
July 13, 2011. Portland, Oregon -The International Cellular Medicine Society (ICMS) announced today another participating clinic in its growing Stem Cell Clinic Accreditation Program. The Brazzini Institute of Interventional Radiology from Lima, Peru signed the contracts late last month, finalizing its involvement in the program.
JUNE 29, 2011. PORTLAND, OREGON – The International Cellular Medicine Society (ICMS), an independent nonprofit organization dedicated to advancing the field of adult cell based medicine, announced today that the Regenerative Medicine Institute (RMI) of Tijuana, Mexico, has successfully undergone and completed the first phases of its formal Stem Cell Clinic Accreditation Process. The program, a 18-month process launched earlier this year has already seen a tremendous amount of participation from stem cell clinics around the world.
June 11, 2011 . PORTLAND, OREGON and TIJUANA, MEXICO – The Sociedad Mexicana de Medicina Regenerativa (SOMMER) and the International Cellular Medicine Society (ICMS) announced a strategic alliance today. The two groups are partnering to bring greater transparency, increased peer oversight and new standards to clinics practicing autologous, adult stem cell medicine in Mexico
MAY 10, 2011. PORTLAND, OREGON – The International Cellular Medicine Society (ICMS) announced today the second participating clinic in its Stem Cell Clinic Accreditation Program. Formal contracts have been signed by World Stem Cells, LLC (WSC) on behalf of its exclusive contract clinic, Advanced Cellular Medicine Clinic in Cancun, Mexico.
MARCH 31, 2011. PORTLAND, OREGON – The International Cellular Medicine Society has accomplished a significant milestone through its Stem Cell Patient Treatment Registry. Today the Society announced that the ICMS Treatment Registry has reached over 750 patient cases being tracked. As a nonprofit organization dedicated to ensuring patient safety, facilitating physician education, and providing peer oversight, this level of oversight and transparency is a significant landmark for the for the field and promise of cell based medicine.
MARCH 15, 2011. PORTLAND, OREGON – The International Cellular Medicine Society (ICMS) publically announced today the first participating clinic in its new Stem Cell Clinic Accreditation Program. The Society entered into its first, formal agreement with the Regenerative Medicine Institute (RMI) of Tijuana, Mexico, a leading stem cell treatment provider in Latin America.
MARCH 1, 201.1 PORTLAND, OREGON - The International Cellular Medicine Society (ICMS), an international nonprofit organization dedicated to patient safety, physician education, and peer oversight, announced today the creation of a new Medical Advisory Board. The Society has created this board to provide a leadership role in its continuous development of clinical guidelines, practice standards, and adjudication review for cell based medical therapies.
PORTLAND, OREGON, FEBRUARY 21, 2011 – Today, the International Cellular Medicine Society (ICMS) announced the conclusions from its investigation into the medical practices of RNLBio, and published the requirements for the South Korean company to come into compliance with ICMS Guidelines. The ICMS, a global nonprofit organization committed to advancing the field of cell based medicine through patient safety, physician education, and peer oversight, undertook this investigation after completing its adjudication of two patient deaths reported at clinics associated RNLBio in November, 2010. More
PORTLAND, OR, February 4, 2011 – In response to the unprecedented proliferation of non US-based stem cell clinics and the continued growth of patients traveling abroad to seek innovative cell based therapies, the International Cellular Medicine Society (ICMS) announced today a new Stem Cell Clinic Accreditation Program. The Society, an international medical nonprofit organization dedicated to patient safety, physician education, and peer oversight of cell based medical therapies, developed this program to bring transparency to these medical procedures.
2010 release index
PORTLAND, OR, DECEMBER 13, 2010- The International Cellular Medicine Society (ICMS) today announced the findings of its investigation into the cause of the deaths of two patients of RNL Bio, a Korean company engaged in the medical removal, banking and provision of stem cells for use in patients. The patients had both received intravenous infusions of stem cells that had been derived from their own fat tissue.
PORTLAND, OREGON, SEPTEMBER 30, 2010 – The International Cellular Medicine Society (ICMS), a nonprofit organization committed to patient safety, peer oversight, and physician education in the medical use of adult stem cells, announces the 2nd Annual International Congress on Regenerative and Cell Based Medicine on November 11-12, 2010 at the M Resort in Las Vegas, NV. This professional medical conference brings together experts who are driving the field of adult stem cell technologies as part of their everyday practice of medicine. The ICMS will host lectures from physicians from around the world on how adult stem cells are being used in the clinical setting to treat patients.
PORTLAND, OREGON, August 4, 2010 – The International Cellular Medicine Society’s (ICMS) Executive Director, David Audley, delivered the opening remarks for the 4th Annual Symposium on Regenerative Medicine and Adult Stem Cell Research in Kyoto, Japan. The ICMS is a global nonprofit organization dedicated to patient safety and education on the medical use of adult stem cells. Audley’s remarks called for physicians worldwide to unite behind best practice standards for the medical use of stem cells.
PORTLAND, OREGON, August 2, 2010 – The International Cellular Medicine Society (ICMS), a nonprofit organization dedicated to patient safety and physician education on the medical use of adult stem cells, announces the publication of an Open Letter directed to stem cell clinics worldwide. The letter, currently published on the ICMS website, warns clinics about impending threats to the future of cell based medicine and encourages them to join the ICMS, participate in its Treatment Registry, and come into compliance with its physician developed international guidelines.
PORTLAND, OREGON. June 29, 2010 - The International Cellular Medicine Society (ICMS), a nonprofit organization dedicated to patient safety and education on the medical use of adult stem cells, today proudly announces the addition of esteemed bioethicist Glenn McGee, PhD to its Board of Directors.
PORTLAND, OREGON, June 4, 2010 – The International Cellular Medicine Society (“ICMS”), a professional medical nonprofit organization dedicated to patient safety through the advancement of safe and effective adult stem cell therapy, applauds the efforts of governmental agencies and nonprofit organization to bring greater transparency to the practices of international stem cell clinics. The ICMS asserts that only through the independent collection and validation of patient outcome data can the promise of adult, autologous stem cell therapies be realized.